Investment Thesis
Axcelis demonstrates exceptional financial health with fortress-like liquidity (4.77x current ratio, 0.01x debt/equity) and strong operational efficiency (14.3% net margin, 88.6x interest coverage). The company generates substantial free cash flow ($107M, 12.8% FCF margin) with minimal capital requirements, providing significant capital deployment flexibility for shareholder returns or strategic investments.
ACLS Strengths
- Exceptional balance sheet strength with minimal leverage and $145.5M cash
- Robust free cash flow generation at $107M with healthy 12.8% FCF margin
- Consistent profitability with 14.3% net margin and 14.2% operating margin
- Outstanding liquidity position with 4.77x current ratio and 3.11x quick ratio
- Strong interest coverage of 88.6x indicates minimal financial distress risk
- Reliable operating cash flow of $118.3M with efficient capital allocation
ACLS Risks
- Revenue stagnation at 0.0% YoY growth despite operational efficiency indicates market saturation or competitive headwinds
- Diluted EPS declined 38.2% YoY suggesting share dilution or one-time charges masking underlying earnings quality
- Modest ROE of 11.6% and ROA of 8.8% indicate below-average returns on shareholder capital
- Zero revenue growth in specialty machinery sector may reflect cyclical demand or loss of market share
- Heavy reliance on operational discipline rather than organic growth suggests limited expansion opportunities
Key Metrics to Watch
- Revenue growth trajectory and market demand indicators for specialty machinery equipment
- Free cash flow sustainability and trends in capital expenditure requirements
- Gross margin expansion/contraction as proxy for pricing power and production efficiency
- Debt levels and capital structure changes given significant cash position
- Return on equity improvement through either margin expansion or working capital optimization
ACLS Financial Metrics
Revenue
$839.0M
Net Income
$120.2M
EPS (Diluted)
$3.80
Free Cash Flow
$107.0M
Total Assets
$1.4B
Cash Position
$145.5M
ACLS Profitability Ratios
Gross Margin
44.9%
Operating Margin
14.2%
Net Margin
14.3%
ROE
11.6%
ROA
8.8%
FCF Margin
12.8%
ACLS Balance Sheet & Liquidity
Current Ratio
4.77x
Quick Ratio
3.11x
Debt/Equity
0.01x
Debt/Assets
24.0%
Interest Coverage
88.64x
Long-term Debt
$13.7M
ACLS 5-Year Financial Trend
Revenue
Net Income
EPS (right axis)
ACLS Growth Metrics (YoY)
Revenue Growth
N/A
Net Income Growth
N/A
EPS Growth
N/A
FCF Margin
12.8%
ACLS Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $213.6M | $26.0M | $0.83 |
| Q2 2025 | $194.5M | $28.6M | $0.98 |
| Q1 2025 | $192.6M | N/A | $0.88 |
| Q3 2024 | $256.6M | N/A | $1.49 |
| Q2 2024 | $256.5M | N/A | $1.55 |
| Q1 2024 | $252.4M | N/A | $1.43 |
| Q3 2023 | $229.2M | N/A | $1.21 |
| Q2 2023 | $221.2M | N/A | $1.32 |
ACLS Capital Allocation
Operating Cash Flow
$118.3M
Cash generated from operations
Stock Buybacks
$121.1M
Shares repurchased (TTM)
Capital Expenditures
$11.3M
Investment in assets
Dividends
None
No dividend program
ACLS SEC Filings
Access official SEC EDGAR filings for AXCELIS TECHNOLOGIES INC (CIK: 0001113232)
Disclaimer: This analysis is generated by Claude AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: Mar 19, 2026 |
Data as of: 2025-12-31 |
Powered by Claude AI